- Home
- WATT vs GOVX Comparison
WATT vs GOVX Comparison
Compare WATT & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WATT
- GOVX
- Stock Information
- Founded
- WATT 2012
- GOVX 2001
- Country
- WATT United States
- GOVX United States
- Employees
- WATT N/A
- GOVX N/A
- Industry
- WATT Radio And Television Broadcasting And Communications Equipment
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- WATT Technology
- GOVX Health Care
- Exchange
- WATT Nasdaq
- GOVX Nasdaq
- Market Cap
- WATT 15.1M
- GOVX 16.8M
- IPO Year
- WATT 2014
- GOVX N/A
- Fundamental
- Price
- WATT $7.31
- GOVX $0.51
- Analyst Decision
- WATT
- GOVX Strong Buy
- Analyst Count
- WATT 0
- GOVX 3
- Target Price
- WATT N/A
- GOVX $10.67
- AVG Volume (30 Days)
- WATT 207.2K
- GOVX 696.9K
- Earning Date
- WATT 10-29-2025
- GOVX 11-07-2025
- Dividend Yield
- WATT N/A
- GOVX N/A
- EPS Growth
- WATT N/A
- GOVX N/A
- EPS
- WATT N/A
- GOVX N/A
- Revenue
- WATT $1,976,000.00
- GOVX $6,143,044.00
- Revenue This Year
- WATT $788.93
- GOVX N/A
- Revenue Next Year
- WATT $176.40
- GOVX N/A
- P/E Ratio
- WATT N/A
- GOVX N/A
- Revenue Growth
- WATT 434.05
- GOVX 1943.07
- 52 Week Low
- WATT $3.67
- GOVX $0.43
- 52 Week High
- WATT $81.00
- GOVX $3.88
- Technical
- Relative Strength Index (RSI)
- WATT 44.86
- GOVX 38.95
- Support Level
- WATT $6.92
- GOVX $0.54
- Resistance Level
- WATT $7.84
- GOVX $0.61
- Average True Range (ATR)
- WATT 0.73
- GOVX 0.03
- MACD
- WATT -0.18
- GOVX -0.00
- Stochastic Oscillator
- WATT 13.26
- GOVX 16.81
About WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs, and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. The WPN technology provides a comprehensive suite of capabilities designed to power the next generation of wireless energy networks, seamlessly delivering power and data across diverse, battery-free device ecosystems. It enhances operational visibility, control, and intelligent business automation. Its products include Transmitter IC & Module, Receivers IC, Transmitter System, and Evaluation Kits.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.